Andreas Halvorsen - Viking Global Investors
Holding/activity history for Teva Pharmaceutical Industries Ltd. (TEVA)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | 0 | 0.00 | Sell 100.00% | 0.13 | SEC | ||
| 2025 Q3 | 2,532,119 | 0.13 | Reduce 78.32% | 0.45 | $20.20 | $51,148,804 | SEC |
| 2025 Q2 | 11,681,333 | 0.57 | Add 15.37% | 0.08 | $16.76 | $195,779,141 | SEC |
| 2025 Q1 | 10,125,478 | 0.49 | Add 55.69% | 0.18 | $15.37 | $155,628,597 | SEC |
| 2024 Q4 | 6,503,485 | 0.46 | Reduce 14.06% | 0.07 | $22.04 | $143,336,809 | SEC |
| 2024 Q3 | 7,567,533 | 0.50 | Buy | 0.50 | $18.02 | $136,366,945 | SEC |
| 2016 Q4 | 0 | 0.00 | Sell 100.00% | 4.01 | SEC | ||
| 2016 Q3 | 19,684,219 | 4.01 | Reduce 29.03% | 1.74 | $46.01 | $905,671,000 | SEC |
| 2016 Q2 | 27,736,655 | 6.00 | Reduce 15.88% | 1.25 | $50.23 | $1,393,212,000 | SEC |
| 2016 Q1 | 32,971,622 | 7.88 | Add 31.66% | 1.89 | $53.51 | $1,764,311,000 | SEC |
| 2015 Q4 | 25,043,775 | 6.54 | Add 182.26% | 4.22 | $65.64 | $1,643,873,000 | SEC |
| 2015 Q3 | 8,872,650 | 2.08 | Buy | 2.08 | $56.46 | $500,950,000 | SEC |
| 2015 Q2 | 0 | 0.00 | Sell 100.00% | 0.06 | SEC | ||
| 2015 Q1 | 228,600 | 0.06 | Buy | 0.06 | $62.30 | $14,242,000 | SEC |